GSK Puts Up $900M To Boost Stake In Indian Unit
British health care titan GlaxoSmithKline PLC has acquired a majority stake in its Indian consumer health care subsidiary for roughly 48 billion rupees ($900 million) after completing a two-week open stock...To view the full article, register now.
Already a subscriber? Click here to view full article